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letter to editorPrimary cutaneous
T cell lymphoma with
bone marrow inﬁltration
and erythroblastopenia –
A rare association
To the Editor: Pure red cell apla-
sia (PRCA) is associated with var-
ious mature and precursor B and
T lymphoproliferative disorders.
However, its association with pri-
mary cutaneous T cell lymphoma
(CTCL) is distinctly rare. We re-
port an uncommon association of
primary CTCL with erythroblas-
topenia and bone marrow (BM)
inﬁltration with overall features
suggestive of a paraneoplastic
PRCA.
A 30-year-old female presented
with history of gradually progres-
sive ulcero-nodular lesion over
her lower limb (Figure 1A). The
skin biopsy showed features con-
sistent with primary CTCL con-
ﬁrmed by immunohistochemistry
(Figure 1B–E) Positron emission
tomography scan showed extensive
involvement of subcutaneous and
intramuscular planes of the leg
and thigh, as well as the underlying
bone. The external iliac, inguinal,
and femoral lymph nodes also
showed involvement. During hos-
pital stay, her general condition
worsened, and she developed a
sudden drop in hemoglobin
(105–40 g/L), reticulocytopenia
(0.44%) and thrombocytopenia
(84 · 109/L). Total leukocyte
count was normal (4.6 · 109/L).
Peripheral smear showed neutro-
philia with occasional myelocytes
and nucleated RBCs. However,
there were no atypical cells. BM
examination showed erythroblas-
topenia (Figure 1F) and matura-Hematol Oncol Stem Cell Ther 7(2) Second Quarter 2tion arrest at proerythroblast
stage, which constitute around
4% of all nucleated cells in the
BM. There were no viral
cytopathic changes. Trephine
biopsy showed focal inﬁltration
by CTCL (Figure 1G–I) with
the rest of the areas showing pre-
served hematopoiesis except for
marked erythroblastopenia. The
patient succumbed to her illness
before starting deﬁnite chemother-
apy and died of multiorgan
dysfunction.
PRCA is an inherited or ac-
quired condition characterized by
reticulocytopenia (<1%) and
erythroblastopenia (<0.5%) with
normal production of myeloid
and megakaryocytic lineages.1
PRCA can be classiﬁed as congen-
ital, primary or idiopathic and sec-
ondary. PRCA is reported to be
associated with chronic lympho-
cytic leukemia, diffuse large cell
lymphoma, splenic marginal zone
lymphoma, T cell large granular
leukemia (T-LGL), angioimmun-
oblastic T cell lymphoma (AITL),
follicular lymphoma, myelomas,
myelodysplastic syndrome, acute
leukemia, Hodgkin’s lymphoma,
Waldenström’s macroglobuline-
mia, chronic myelogenous leuke-
mia, primary myeloﬁbrosis and
essential thrombocythemia.1,2 In
one of the largest studies from
Japan, lymphoma was seen in eight
out of 185 patients with PRCA.3
A previous study from our insti-
tute had one case of NHL out of
nine cases with PRCA.4 One of
the recent reviews shows that the
most common lymphoproliferative
disorder associated with PRCA is
T-LGL followed by AITL.2
Primary CTCLs are uncommon014 hemoncstem.edmgr.comlymphomas, which present as
patches, plaques or nodular lesions
with or without ulceration. Some
of them can lead to hematological
manifestations, especially cd T cell
lymphomas which can present
with secondary hemophagocyto-
sis.5 BM involvement can occur
in these tumors in up to 12–20%
of cases.6,7 There is only a single
case of mycosis fungoides associ-
ated with PRCA in the literature.3
Possible mechanisms of PRCA in
lymphoproliferative disorders in-
clude antibody mediated cytotoxic
or complement mediated injury
to erythroid precursors, cytotoxic
or cytokine mediated injury
induced by monoclonal or poly-
clonal expansion of T cells or
NK cells.2 Our case showed inﬁl-
tration of BM by CTCL associated
with erythroblastopenia and clini-
cally behaving like a PRCA. There
was only a patchy involvement of
the BM by CTCL with preserved
areas showing marked erythroblas-
topenia and preservation of all
other hematopoietic elements,
which suggests that the erythro-
blastopenia is probably an indirect
or paraneoplastic effect, and not
due to direct BM inﬁltration.
Though there are reports and re-
views associating PRCA with lym-
phomas, the association of CTCL
with erythroblastopenia is
distinctly rare. Moreover, the exact
incidence and clinical impact of
erythroblastopenia in such a
situation is unclear in the
literature.CONFLICT OF INTEREST
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Figure 1. Ulcero-nodular lesions over lower limb (A). Skin biopsy shows dermal and subcutaneous nodular aggregates and sheets of atypical
lymphoid cells without epidermotropism (H&E, 4· & 20·) (B & C); cells are positive for CD3 (D) and LCA (not shown); negative for CD20 (E), CD4,
CD8, CD79a, CD30, CD138, CD38, and CD56 (not shown). Bone marrow aspirate shows occasional proerythroblasts (MGG, 100·) (F). Bone marrow
trephine biopsy shows infiltration by atypical lymphoid cells admixed with histiocytes, plasma cells and eosinophils (H & E, 20·) (G) which were
positive for CD3 (H), in a background of fibrosis (reticulin stain, 20·) (I).
100 Hematol Oncol Stem Cell Ther 7(2) Second Quarter 2014 hemoncstem.edmgr.com
letter to editor
letter to editor
Sreejesh Sreedharanunni a,
Man Updesh Singh
Sachdeva a,*,
Bishan Radotra b,
Anusree Prabhakaran c,
Gaurav Prakash c
a Department of Hematology, Post
Graduate Institute of Medical
Education and Research, Chandigarh,
India, b Department of Histopathology,
Post Graduate Institute of Medical
Education and Research, Chandigarh,
India, c Department of Internal
Medicine, Post Graduate Institute of
Medical Education and Research,
Chandigarh, India
* Corresponding author. Address:
Department of Hematology, PostHematol Oncol Stem Cell Ther 7(2) Second Quarter 2Graduate Institute of Medical
Education and Research, Chandigarh
160012, India. Tel.: +91 172 2755128;
fax: +91 172 2744401
drmanupdeshpgi@yahoo.co.in
ª 2014 King Faisal Specialist Hospital &
Research Centre. Published by Elsevier Ltd.
All rights reserved.
DOI: http://dx.doi.org/10.1016/
j.hemonc.2014.01.003
REFERENCES
1. Dessypris EN, Lipton JM. Pure red cell aplasia.
In: Greer JP, Foerster J, Rodgers GM, et al., editors.
Wintrobe's clinical hematology, 1. Philadelphia
PA: Lippincot Williams & Wilkins; 2009. p.
1196–207.
2. Vlachaki E, Diamantidis MD, Klonizakis P, Haral-
ambidou-Vranitsa S, Ioannidou-Papagiannaki E,
Klonizakis I. Pure red cell aplasia and lymphoprolif-014 hemoncstem.edmgr.comerative disorders: an infrequent association. Sci
World J 2012:475313 Epub 2012 April 19.
PMC3349208.
3. Hirokawa M, Sawada K, Fujishima N, Kawano F,
Kimura A, Watanabe T, et al. Acquired pure red cell
aplasia associated with malignant lymphomas: a
nationwide cohort study in Japan for the PRCA
Collaborative Study Group. Am J Hematol
2009;84(3):144–8.
4. Malhotra P, Muralikrishna GK, Varma N, Kumari
S, Das R, Ahluwalia J, et al. Spectrum of pure red
cell aplasia in adult population of north-west India.
Hematology 2008;13(2):88–91.
5. Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H, et al., editors. WHO classification
of tumours of haematopoietic and lymphoid tis-
sues. Lyon: France, IARC Press; 2008.
6. Mart RM, Estrach T, Reverter JC, Campo E,
Brugues R, Bruguera M, et al. Utility of bone
marrow and liver biopsies for staging cutaneous T-
cell lymphoma. Int J Dermatol 1996;35(6):450–4.
7. Salhany KE, Greer JP, Cousar JB, Collins RD.
Marrow involvement in cutaneous T-cell lymphoma.
A clinicopathologic study of 60 cases. Am J Clin
Pathol 1989;92(6):747–54.101
